HNF4A and medical procedure: As previously reported, SS treatment can inhibit Wnt/β-catenin signaling to attenuate TCF transcriptional activity [12, 20, 31–33], which is particularly significant for its antineoplastic activity given that stabilized β-catenin is associated with colorectal tumorigenesis.